Zacks: Analysts Expect Cantel Medical Corp. (CMD) Will Announce Quarterly Sales of $227.90 Million

Wall Street analysts expect Cantel Medical Corp. (NYSE:CMD) to report $227.90 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cantel Medical’s earnings, with the lowest sales estimate coming in at $227.00 million and the highest estimate coming in at $228.80 million. Cantel Medical posted sales of $213.03 million in the same quarter last year, which would indicate a positive year over year growth rate of 7%. The company is scheduled to issue its next quarterly earnings report on Thursday, March 14th.

According to Zacks, analysts expect that Cantel Medical will report full-year sales of $937.25 million for the current year, with estimates ranging from $931.80 million to $942.70 million. For the next fiscal year, analysts anticipate that the business will post sales of $1.01 billion, with estimates ranging from $1.01 billion to $1.02 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that that provide coverage for Cantel Medical.

Cantel Medical (NYSE:CMD) last posted its quarterly earnings results on Thursday, November 29th. The company reported $0.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.60 by $0.02. The firm had revenue of $225.59 million for the quarter, compared to analysts’ expectations of $227.70 million. Cantel Medical had a return on equity of 16.73% and a net margin of 9.87%.

Shares of Cantel Medical stock traded up $0.07 on Friday, reaching $80.15. 3,600 shares of the company’s stock were exchanged, compared to its average volume of 158,772. The stock has a market capitalization of $3.34 billion, a price-to-earnings ratio of 31.93 and a beta of 1.18. Cantel Medical has a 52 week low of $69.36 and a 52 week high of $130.92. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.44 and a current ratio of 2.21.

The firm also recently declared a Semi-Annual dividend, which was paid on Thursday, January 31st. Shareholders of record on Thursday, January 17th were issued a dividend of $0.10 per share. This is a boost from Cantel Medical’s previous Semi-Annual dividend of $0.09. The ex-dividend date of this dividend was Wednesday, January 16th. Cantel Medical’s dividend payout ratio is presently 7.97%.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Featured Story: What is the Federal Reserve?

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.

Leave a Reply